The quality control from ZeptoMetrix is formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable.
On May 5, 2020, ZeptoMetrix announced its new, ready-to-use NATtrol, a SARS-CoV-2 molecular quality control for laboratory QC and test validation.
According to a company press release, the quality control is formulated with purified intact viral particles that have been chemically modified to render them non-infectious and refrigerator stable, including:
Complementing the release of the positive control is a negative control formulated with human A549 cells:
"Due to the unprecedented COVID-19 pandemic, we were tasked to develop and deploy reliable, user-friendly commercial solutions for ready-to-use, non-infectious SARS-CoV-2 full process molecular quality controls under accelerated timelines,” said Shawn R. Smith, president and CEO of ZeptoMetrix, in the press release. “Today, I am extremely proud to announce that ZeptoMetrix has launched such controls - containing purified intact viral particles of actual SARS-CoV-2 that provide laboratories, hospitals and research facilities with essential external run controls to help ensure the reliability of COVID-19 testing.”
Source: ZeptoMetrix
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.